|  Help  |  About  |  Contact Us

Publication : MicroRNA-17-92, a direct Ap-2α transcriptional target, modulates T-box factor activity in orofacial clefting.

First Author  Wang J Year  2013
Journal  PLoS Genet Volume  9
Issue  9 Pages  e1003785
PubMed ID  24068957 Mgi Jnum  J:202467
Mgi Id  MGI:5519156 Doi  10.1371/journal.pgen.1003785
Citation  Wang J, et al. (2013) MicroRNA-17-92, a direct Ap-2alpha transcriptional target, modulates T-box factor activity in orofacial clefting. PLoS Genet 9(9):e1003785
abstractText  Among the most common human congenital anomalies, cleft lip and palate (CL/P) affects up to 1 in 700 live births. MicroRNA (miR)s are small, non-coding RNAs that repress gene expression post-transcriptionally. The miR-17-92 cluster encodes six miRs that have been implicated in human cancers and heart development. We discovered that miR-17-92 mutant embryos had severe craniofacial phenotypes, including incompletely penetrant CL/P and mandibular hypoplasia. Embryos that were compound mutant for miR-17-92 and the related miR-106b-25 cluster had completely penetrant CL/P. Expression of Tbx1 and Tbx3, the DiGeorge/velo-cardio-facial (DGS) and Ulnar-mammary syndrome (UMS) disease genes, was expanded in miR-17-92 mutant craniofacial structures. Both Tbx1 and Tbx3 had functional miR seed sequences that mediated gene repression. Analysis of miR-17-92 regulatory regions uncovered conserved and functional AP-2alpha recognition elements that directed miR-17-92 expression. Together, our data indicate that miR-17-92 modulates expression of critical T-box transcriptional regulators during midface development and is itself a target of Bmp-signaling and the craniofacial pioneer factor AP-2alpha. Our data are the first genetic evidence that an individual miR or miR cluster is functionally important in mammalian CL/P.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

30 Bio Entities

0 Expression